Louis Denis

Louis Denis

Company: Verastem. inc

Job title: Chief Medical Officer

Seminars:

Introducing Rational Combinations of RAF/MEK Clamp Avutometinib: Breakthrough Designation & Beyond 2:45 pm

Presenting RAF/MEK clamp Avutometinib and FAK inhibitor Defactinib which are in clinical development in RAS/MAPK driven cancers, offering new hope for patients Demonstrating the potential for improved patient outcomes with registration-directed trial design and clinical development progress in low-grade serous ovarian cancer (LGSOC) and other RAS/ MAPK driven cancers Discussing future directions, including clinical trials…Read more

day: Day Two Track B PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.